These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
648 related articles for article (PubMed ID: 33131409)
1. Depletion of circ_0007841 inhibits multiple myeloma development and BTZ resistance via miR-129-5p/JAG1 axis. Wang Y; Lin Q; Song C; Ma R; Li X Cell Cycle; 2020 Dec; 19(23):3289-3302. PubMed ID: 33131409 [TBL] [Abstract][Full Text] [Related]
2. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis. Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072 [TBL] [Abstract][Full Text] [Related]
3. Circ_0005615 contributes to the progression and Bortezomib resistance of multiple myeloma by sponging miR-185-5p and upregulating IRF4. Fu C; Wang J; Hu M; Zhou W Anticancer Drugs; 2022 Oct; 33(9):893-902. PubMed ID: 36136989 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of hsa_circ_0003489 shifts balance from autophagy to apoptosis and sensitizes multiple myeloma cells to bortezomib via miR-874-3p/HDAC1 axis. Tian FQ; Chen ZR; Zhu W; Tang MQ; Li JH; Zhang XC; Jiang J; Cheng XH J Gene Med; 2021 Sep; 23(9):e3329. PubMed ID: 33625798 [TBL] [Abstract][Full Text] [Related]
5. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p. Zang H; Li Y; Zhang X; Huang G Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of circ_CELSR1 facilitates paclitaxel resistance of ovarian cancer by regulating miR-149-5p/SIK2 axis. Wei S; Qi L; Wang L Anticancer Drugs; 2021 Jun; 32(5):496-507. PubMed ID: 33735118 [TBL] [Abstract][Full Text] [Related]
7. Circ_0085495 knockdown reduces adriamycin resistance in breast cancer through miR-873-5p/integrin β1 axis. Xie H; Zheng R Anticancer Drugs; 2022 Jan; 33(1):e166-e177. PubMed ID: 34387598 [TBL] [Abstract][Full Text] [Related]
8. Circ_0001821 knockdown suppresses growth, metastasis, and TAX resistance of non-small-cell lung cancer cells by regulating the miR-526b-5p/GRK5 axis. Liu Y; Li C; Liu H; Wang J Pharmacol Res Perspect; 2021 Aug; 9(4):e00812. PubMed ID: 34219377 [TBL] [Abstract][Full Text] [Related]
9. Circ_SEC61A1 contributes to the progression of multiple myeloma cells via regulating miR-660-5p/CDK6 axis. Luo Z; Yin Y; Tan X; Liu K; Chao Z; Xia H Leuk Res; 2022 Feb; 113():106774. PubMed ID: 35030455 [TBL] [Abstract][Full Text] [Related]
10. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma. Cheng J; Zhang R; Yan M; Li Y BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028 [TBL] [Abstract][Full Text] [Related]
11. Circ_0006988 promotes the proliferation, metastasis and angiogenesis of non-small cell lung cancer cells by modulating miR-491-5p/MAP3K3 axis. Yang C; Shi J; Wang J; Hao D; An J; Jiang J Cell Cycle; 2021 Jul; 20(13):1334-1346. PubMed ID: 34189997 [TBL] [Abstract][Full Text] [Related]
12. Circular RNA circ-FAM158A promotes retinoblastoma progression by regulating miR-138-5p/SLC7A5 axis. Zheng T; Chen W; Wang X; Cai W; Wu F; Lin C Exp Eye Res; 2021 Oct; 211():108650. PubMed ID: 34102206 [TBL] [Abstract][Full Text] [Related]
13. Circ_0000395 promotes cell growth, metastasis and oxaliplatin resistance by regulating miR-153-5p/MYO6 in colorectal cancer. Xiao L; Zhu Y; Xu H; Lin L; Li M; Zhou Y Pathol Res Pract; 2024 Aug; 260():155476. PubMed ID: 39038387 [TBL] [Abstract][Full Text] [Related]
14. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells. Zhou Y; Zhang S; Min Z; Yu Z; Zhang H; Jiao J BMC Cancer; 2021 Oct; 21(1):1085. PubMed ID: 34620126 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of circ_0058058 suppresses proliferation, angiogenesis and metastasis in multiple myeloma through miR-338-3p/ATG14 pathway. Xue L; Jia T; Zhu Y; Zhao L; Mao J J Orthop Surg Res; 2021 Dec; 16(1):723. PubMed ID: 34930344 [TBL] [Abstract][Full Text] [Related]
16. Circ_0005875 sponges miR-502-5p to promote renal cell carcinoma progression through upregulating E26 transformation specific-1. Luo S; Deng F; Yao N; Zheng F Anticancer Drugs; 2022 Jan; 33(1):e286-e298. PubMed ID: 34407050 [TBL] [Abstract][Full Text] [Related]